Because of a growing menu of effective treatments, people with multiple myeloma (MM ... Two drug classes (other than steroids) that you took before, and At least one drug from a class that ...

The US Food and Drug Administration (FDA) is expected to make a Prescription Drug User Fee Act (PDUFA) decision by mid-2025.

Researchers at the Icahn School of Medicine at Mount Sinai have discovered how genetics can affect the success of venetoclax, ...

A quadruplet regimen is now the preferred first-line treatment for multiple myeloma in both transplant-eligible and ...

Tyler Sandahl, PharmD, of Mayo Clinic, and Michael Byrne, DO, of Tennessee Oncology, discuss practical advice for bringing ...

Multiple myeloma is a kind of blood cancer that affects white blood cells called plasma cells. Abnormal plasma cells crowd out healthy cells in your bone marrow. And they flood your bloodstream ...

Doctors do not usually recommend surgery for multiple myeloma. However, it may be necessary to repair damaged bones, replace bone marrow, or treat spinal cord compression. Surgery to treat ...

steroids and even bortezomib. This approach could be an important consideration in the management of heavily pretreated patients with chemorefractory multiple myeloma, even at the stage of ...

We do not know what causes MGUS. There may be a link to autoimmune diseases, genetics, or environmental factors. Like multiple myeloma, MGUS starts in a type of white blood cell called plasma cells.

A stem cell transplant can be a good treatment for multiple myeloma. A successful transplant gives someone with multiple myeloma new, healthy bone marrow. It replaces the bone marrow harmed by myeloma ...

Melflufen belongs to a novel class of peptidase-enhanced compounds that elicit increased cytotoxicity in target multiple myeloma (MM ... which include alkylators, steroids, immunomodulatory ...

Multiple myeloma is a rare type of cancer. It starts with the uncontrolled production of plasma cells. These are a type of white blood cell in the bone marrow. Healthy plasma cells make antibodies ...